➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Johnson and Johnson
Baxter
AstraZeneca
Merck

Last Updated: May 15, 2021

DrugPatentWatch Database Preview

Dialysis Sups Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for DIALYSIS SUPS, and what generic alternatives to DIALYSIS SUPS drugs are available?

DIALYSIS SUPS has one approved drug.

There is one US patent protecting DIALYSIS SUPS drugs.

There are four patent family members on DIALYSIS SUPS drugs in four countries and fifteen supplementary protection certificates in seven countries.

Summary for Dialysis Sups
International Patents:4
US Patents:1
Tradenames:2
Ingredients:1
NDAs:1

Drugs and US Patents for Dialysis Sups

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006 RX Yes Yes   Get Started for $10   Get Started for $10
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006 RX Yes Yes 7,300,674   Get Started for $10 Y   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Dialysis Sups

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006 5,945,449   Get Started for $10
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006 5,945,449   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Dialysis Sups Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1499331 C300615 Netherlands   Get Started for $10 PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220
1020461 300482 Netherlands   Get Started for $10 PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
0984957 122012000051 Germany   Get Started for $10 PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Mallinckrodt
Dow
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.